Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 10.2 | 0.7 | 0.5 | 1.5 |
| Revenue growth | 1351.7% | 46.0% | -68.2% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 10.2 | 0.7 | 0.5 | 1.5 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 68.1 | 33.5 | 16.2 | 16.1 |
| General and administrative | 14.4 | 10.3 | 3.4 | 2.8 |
| EBIT | -72.4 | -43.2 | -19.2 | -17.3 |
| EBIT margin | -711.2% | -6156.5% | -3993.7% | -1147.1% |
| Pre-tax income | -71.5 | -42.4 | -16.4 | -15.3 |
| Income taxes | 1.7 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% | 0.0% |
| Net income | -73.2 | -42.6 | -16.7 | -14.3 |
| Net margin | -719.5% | -6084.3% | -3474.7% | -946.5% |
| |
| Diluted EPS | ($1.46) | ($2.67) | ($1.10) | ($0.94) |
| Shares outstanding (diluted) | 50.0 | 16.0 | 15.2 | 15.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|